Savings from Off-Year Drug Re-Pricing Should Go Towards Medical Fees: JMA Chief

July 15, 2022
JMA President Kichiro Matsumoto As Japan gears up for full debates on next year’s “off-year” drug re-pricing, Kichiro Matsumoto, new president of the Japan Medical Association (JMA), renewed the group’s call on July 14 for directing savings from such price...read more